Carboxylic Acid Derivatives Display Potential Selectivity for Human Histone Deacetylase 6: Structure-Based Virtual Screening Molecular Docking and Dynamics Simulation Studies

dc.contributor.author Uba, Abdullahi Ibrahim
dc.contributor.author Yelekçi, Kemal
dc.contributor.author Yelekçi, Kemal
dc.contributor.other Molecular Biology and Genetics
dc.date.accessioned 2019-06-27T08:04:44Z
dc.date.available 2019-06-27T08:04:44Z
dc.date.issued 2018
dc.department Fakülteler, Mühendislik ve Doğa Bilimleri Fakültesi, Biyoinformatik ve Genetik Bölümü en_US
dc.description.abstract Human histone deacetylase 6 (HDAC6) has been shown to play a major role in oncogenic cell transformation via deacetylation of alpha-tubulin making it a viable target of anticancer drug design and development. The crystal structure of HDAC6 catalytic domain 2 has been recently made available providing avenues for structure-based drug design campaign. Here in our continuous effort to identify potentially selective HDAC6 inhibitors structure-based virtual screening of similar to 72 461 compounds was carried out using Autodock Vina. The top 100 compounds with calculated Delta G < -10 kcal/mol were manually inspected for binding mode orientation. Furthermore the top 20 compounds with reasonable binding modes were evaluated for selectivity by further docking against HDAC6 and HDAC7 using Autodock4. Four compounds with a carboxylic fragment displayed potential selectivity for HDAC6 over HDAC7 and were found to have good druglike and ADMET properties. Their docking complexes were then submitted to 10 ns-molecular dynamics (MD) simulation using nanoscale MD (NAMD) software to examine the stability of ligand binding modes. These predicted inhibitors remained bound to HDAC6 in the presence of water and ions and the root-mean-square deviation (RMSD) radius of gyration (Rg) and nonbond distance (protein-ligand) profiles suggested that they might be stable over time of the simulation. This study may provide scaffolds for further lead optimization towards the design of HDAC6 inhibitors with improved selectivity. (C) 2018 Elsevier Ltd. All rights reserved. en_US]
dc.identifier.citationcount 18
dc.identifier.doi 10.1016/j.compbiolchem.2018.05.004 en_US
dc.identifier.endpage 142
dc.identifier.issn 1476-9271 en_US
dc.identifier.issn 1476-928X en_US
dc.identifier.issn 1476-9271
dc.identifier.issn 1476-928X
dc.identifier.pmid 29859380 en_US
dc.identifier.scopus 2-s2.0-85047621342 en_US
dc.identifier.scopusquality Q2
dc.identifier.startpage 131 en_US
dc.identifier.uri https://hdl.handle.net/20.500.12469/981
dc.identifier.uri https://doi.org/10.1016/j.compbiolchem.2018.05.004
dc.identifier.volume 75 en_US
dc.identifier.wos WOS:000437057500015 en_US
dc.institutionauthor Uba, Abdullahi Ibrahim en_US
dc.language.iso en en_US
dc.publisher Elsevier Science en_US
dc.relation.journal Computational Biology and Chemistry en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.scopus.citedbyCount 19
dc.subject Structure-based virtual screening en_US
dc.subject ADMET prediction en_US
dc.subject Molecular docking en_US
dc.subject Molecular dynamics simulation en_US
dc.subject HDAC6-selective inhibitors en_US
dc.subject Carboxylic acid derivatives en_US
dc.title Carboxylic Acid Derivatives Display Potential Selectivity for Human Histone Deacetylase 6: Structure-Based Virtual Screening Molecular Docking and Dynamics Simulation Studies en_US
dc.type Article en_US
dc.wos.citedbyCount 18
dspace.entity.type Publication
relation.isAuthorOfPublication 9407938e-3d31-453b-9199-aaa8280a66c5
relation.isAuthorOfPublication.latestForDiscovery 9407938e-3d31-453b-9199-aaa8280a66c5
relation.isOrgUnitOfPublication 71ce8622-7449-4a6a-8fad-44d881416546
relation.isOrgUnitOfPublication.latestForDiscovery 71ce8622-7449-4a6a-8fad-44d881416546

Files